ClinicalTrials.Veeva

Menu

Evaluation of the Effectiveness of Home-Use Desensitizing Agents on Dentin Hypersensitivity

Ç

Çanakkale Onsekiz Mart University

Status

Completed

Conditions

Dentin Sensitivity

Treatments

Other: Casein Phosphopeptide Amorphous Calcium Phosphate
Other: Arginine
Other: Control group
Other: Potassium Nitrate
Other: Novamin
Other: Propolis

Study type

Interventional

Funder types

Other

Identifiers

NCT06216262
TSA-2023-4535

Details and patient eligibility

About

Dentin sensitivity is one of the most common problems in society and affects the quality of life related to oral health. Agents such as toothpaste, mouthwash, and dental cream are home-type desensitizing agents used as the first step in the treatment of dentin hypersensitivity. A total of 180 individuals with dentin sensitivity will be included in the study and the individuals will be randomly divided into 6 groups. Individuals in the 1st Group will be given arginine-containing toothpaste, individuals in the 2nd Group will be given novamin-containing toothpaste, individuals in the 3rd Group will be given propolis-containing toothpaste, individuals in the 4th Group will be given casein phosphopeptide amorphous calcium phosphate-containing dental cream, and individuals in the 5th Group will be given mouthwash containing potassium nitrate. Classic toothpaste with 1450 ppm fluoride will be distributed to individuals in the control group, which is the 6th group. The Dentin Hypersensitivity Experience Questionnaire (DHEQ-15), consisting of 15 questions, will be used to evaluate dentin sensitivity. Visual Analogue Scale (VAS) will be used to determine the individual's pain score in dentin sensitivity, and the individual will be asked to score the intensity of pain experienced between 0-10 points. Finally, in the evaluation of dentin sensitivity, a single dentist will apply air to the cervix of the tooth from a distance of 1 cm for 1 second, and the Schiff Sensitivity Scale score will be determined through clinical examination. A score between 0 and 3 will be determined by the dentist according to the patient's response to the air stimulus. The effectiveness of the home-use desensitizing agents used in the treatment of dentin hypersensitivity was evaluated with DHEQ-15, VAS and Schiff Sensitivity Scale; Baseline, 4th and 8th week scores will be compared.

Enrollment

180 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between 18-70 years old
  • General health condition is good
  • Individuals with sensitivity in 2 or more non-adjacent teeth

Exclusion criteria

  • Pregnant or breastfeeding women
  • Advanced periodontal diseases
  • Chronic diseases that may affect the study results
  • Major oral pathologies
  • Use of anticonvulsant, antihistamine, antidepressant, sedative, tranquilizer medication
  • Use of desensitizing paste in the last 3 months
  • Individuals who have been treated for periodontal disease in the last 12 months

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

180 participants in 6 patient groups

Control group
Active Comparator group
Description:
1450 ppm fluoride toothpaste
Treatment:
Other: Control group
Arginine
Active Comparator group
Description:
toothpaste containing arginine
Treatment:
Other: Arginine
Novamin
Active Comparator group
Description:
toothpaste containing novamin
Treatment:
Other: Novamin
Propolis
Active Comparator group
Description:
toothpaste containing propolis
Treatment:
Other: Propolis
Casein Phosphopeptide Amorphous Calcium Phosphate
Active Comparator group
Description:
Dental cream containing casein phosphopeptide amorphous calcium phosphate
Treatment:
Other: Control group
Other: Casein Phosphopeptide Amorphous Calcium Phosphate
Potassium Nitrate
Active Comparator group
Description:
mouthwash containing potassium nitrate
Treatment:
Other: Potassium Nitrate
Other: Control group

Trial contacts and locations

1

Loading...

Central trial contact

Gizem AYAN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems